SEO URLwww.firestrike.ai/deals/organon-sun-pharma-acquisition-2026-1
acquisitionAnnounced · Apr 26, 2026PharmaceuticalsSource · CredibleArticle · Factual
Sun Pharma acquires Organon
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$12.5B
Target
Organon
NYSE: OGN · Jersey City, New Jersey
Acquirer
Sun Pharma
Full Acquisition
Status
Pending
Sun Pharma agreed to acquire Organon. Reported deal value: $12.5B. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Jersey City, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-04-26. Figures and status may change as filings and press coverage update.
Mumbai: India most valuable drug maker Sun Pharmaceutical Industries is set to make its biggest and most ambitious overseas acquisition till date, a near $12.5 billion acquisition of New Jersey-based Organon &Co., said people with knowledge of the development
Deal timeline
Announced
Apr 26, 2026 · m.economictimes.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $12.5B. Figures and status may change as sources update.
Sources: m.economictimes.com · Primary article · FireStrike proprietary index